Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics

NCT04859062
terminatedphase_4

Nitrous Oxide for Analgesia During Office Urethral Bulking

NCT03847922
completedphase_4

Lidocaine for Pain After Urodynamic Testing

NCT03390790
completedphase_3

Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation

NCT02852434

Clinical Trials (4)

Showing 4 of 4 trials
NCT04859062Not Applicable

Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics

Completed
NCT03847922Phase 4

Nitrous Oxide for Analgesia During Office Urethral Bulking

Terminated
NCT03390790Phase 4

Lidocaine for Pain After Urodynamic Testing

Completed
NCT02852434Phase 3

Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4